116 related articles for article (PubMed ID: 3899418)
1. Double-blind comparison of indapamide with a placebo in hypertensive patients treated by practicing physicians.
Schaller MD; Waeber B; Brunner HR
Clin Exp Hypertens A; 1985; 7(7):985-94. PubMed ID: 3899418
[TBL] [Abstract][Full Text] [Related]
2. Long-term efficacy of a new, fixed, very-low-dose angiotensin-converting enzyme-inhibitor/diuretic combination as first-line therapy in elderly hypertensive patients.
Chalmers J; Castaigne A; Morgan T; Chastang C
J Hypertens; 2000 Mar; 18(3):327-37. PubMed ID: 10726720
[TBL] [Abstract][Full Text] [Related]
3. Indapamide versus beta-blocker therapy: a double-blind, crossover study in essential hypertension.
Rumboldt Z; Rumboldt M; Jurisic M
Curr Med Res Opin; 1984; 9(1):10-20. PubMed ID: 6373155
[TBL] [Abstract][Full Text] [Related]
4. Indapamide in the treatment of essential arterial hypertension: results of a controlled study.
Plante GE; Robillard C
Curr Med Res Opin; 1983; 8 Suppl 3():59-66. PubMed ID: 6352186
[TBL] [Abstract][Full Text] [Related]
5. Clinical efficacy and safety of indapamide in essential hypertension.
Morledge JH
Am Heart J; 1983 Jul; 106(1 Pt 2):229-32. PubMed ID: 6346846
[TBL] [Abstract][Full Text] [Related]
6. Multicenter dose-response study of the effect of indapamide in the treatment of patients with mild to moderate hypertension.
Capone P; Vukovich RA; Neiss ES; Bolton S; Reeves RL
Clin Ther; 1983; 5(3):305-16. PubMed ID: 6342786
[TBL] [Abstract][Full Text] [Related]
7. Comparative study on the antihypertensive efficacy of torasemide and indapamide in patients with essential hypertension.
Spannbrucker N; Achhammer I; Metz P; Glocke M
Arzneimittelforschung; 1988 Jan; 38(1A):190-3. PubMed ID: 3285833
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of indapamide in the treatment of hypertension.
Anavekar SN; Ludbrooke A; Louis WJ; Doyle AE
J Cardiovasc Pharmacol; 1979; 1(4):389-94. PubMed ID: 94616
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of indapamide 1.25 mg once daily in elderly patients with mild to moderate hypertension.
Fiddes R; Blumenthal J; Dawson JE; Dyckman E; St John Hammond PG; Harris S; Lasseter KC; Levine BS; Montoro R; Niederman AL; Ratner PH; Rosenblatt S; Toth PD; Vergis J; Codispoti J
J Hum Hypertens; 1997 Apr; 11(4):239-44. PubMed ID: 9185029
[TBL] [Abstract][Full Text] [Related]
10. [Therapeutic benefit of a low dose of indapamide: results of a double-blind against placebo European controlled study].
Asmar R; Guez D; Malbezin M; Brault Y; de Cordoue A; Barrandon S; Bruxelles MC; Chastang C
Arch Mal Coeur Vaiss; 1995 Aug; 88(8):1083-7. PubMed ID: 8572850
[TBL] [Abstract][Full Text] [Related]
11. Low-dose antihypertensive therapy with 1.5 mg sustained-release indapamide: results of randomised double-blind controlled studies. European study group.
Ambrosioni E; Safar M; Degaute JP; Malin PL; MacMahon M; Pujol DR; de Cordoüe A; Guez D
J Hypertens; 1998 Nov; 16(11):1677-84. PubMed ID: 9856369
[TBL] [Abstract][Full Text] [Related]
12. Efficacious response with lower dose indapamide therapy in the treatment of elderly patients with mild to moderate hypertension.
Weidler D; Jallad NS; Curry C; Ferdinand K; Jain AK; Schnaper HW; Toth PD; Codispoti J; Stokes A; McNally C
J Clin Pharmacol; 1995 Jan; 35(1):45-51. PubMed ID: 7751412
[TBL] [Abstract][Full Text] [Related]
13. Clinical evaluation of muzolimine and indapamide during treatment for essential hypertension.
Kirsten R; Molz KH; Tzonev I; Nelson K
Z Kardiol; 1985; 74 Suppl 2():66-72. PubMed ID: 4002807
[TBL] [Abstract][Full Text] [Related]
14. Lower dose diuretic therapy in the treatment of patients with mild to moderate hypertension.
Hall WD; Weber MA; Ferdinand K; Flamenbaum W; Marbury T; Jain AK; Weidler D; Weiss R; Herron J; Codispoti J
J Hum Hypertens; 1994 Aug; 8(8):571-5. PubMed ID: 7990083
[TBL] [Abstract][Full Text] [Related]
15. Indapamide SR versus candesartan and amlodipine in hypertension: the X-CELLENT Study.
London G; Schmieder R; Calvo C; Asmar R
Am J Hypertens; 2006 Jan; 19(1):113-21. PubMed ID: 16461202
[TBL] [Abstract][Full Text] [Related]
16. Regression of left ventricular hypertrophy in patients with essential hypertension. Results of 6 month treatment with indapamide.
Curry CL; Robinson H; Brown R; Olivan J; Sami M; Honos G; Ruddy TD; Balazovjech I; Touzek F; Galinier F; Mariani M; de Cordoüe A; Barrandon S; Brault Y; Guez D
Am J Hypertens; 1996 Aug; 9(8):828-32. PubMed ID: 8862231
[TBL] [Abstract][Full Text] [Related]
17. [The comparison of the effect of enalapril and indapamide on the peripheral blood pressure and central blood pressure through pulse wave analysis].
Jiang XJ; Li QY; Zhang YQ; Liu GZ; Liu LS
Zhonghua Xin Xue Guan Bing Za Zhi; 2005 Oct; 33(10):885-8. PubMed ID: 16266472
[TBL] [Abstract][Full Text] [Related]
18. Hypertension in elderly patients. A comparative study between indapamide and hydrochlorothiazide.
Plante GE; Dessurault DL
Am J Med; 1988 Jan; 84(1B):98-103. PubMed ID: 3341391
[TBL] [Abstract][Full Text] [Related]
19. Indapamide and atenolol in the treatment of hypertension: double-blind comparative and combination study.
De Divitiis O; Di Somma S; Petitto M; Fazio S; Ligouri V
Curr Med Res Opin; 1983; 8(7):493-500. PubMed ID: 6354604
[TBL] [Abstract][Full Text] [Related]
20. Combination of an ACE inhibitor and indapamide improves blood pressure control, but attenuates the beneficial effects of ACE inhibition on plasma adiponectin in patients with essential hypertension.
Huang SS; Wu TC; Lin SJ; Chen JW
Circ J; 2009 Dec; 73(12):2282-7. PubMed ID: 19789415
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
